These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 487370)

  • 1. Technetium-99m stannous pyrophosphate "hot spot" imaging to detect acute myocardial infarcts.
    Willerson JT; Parkey RW; Buja LM; Bonte FJ
    Cardiovasc Clin; 1979; 10(2):139-48. PubMed ID: 487370
    [No Abstract]   [Full Text] [Related]  

  • 2. A computer-based scintigraphic method for sizing acute inferior myocardial infarcts.
    Lewis MH; Buja LM; Parkey RW; Mishelevich DJ; Bonte FJ; Saffer SI; Richmond JR; Willerson JT
    Radiology; 1980 Aug; 136(2):439-42. PubMed ID: 7403522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technetium-99m stannous pyrophosphate myocardial scintigraphy].
    Tada A; Bungyo H; Hisada K
    Rinsho Hoshasen; 1983 Feb; 28(2):345-6. PubMed ID: 6865056
    [No Abstract]   [Full Text] [Related]  

  • 4. Technetium 99m stannous pyrophosphate myocardial scintigraphy to detect myocardial necrosis.
    Willerson JT
    West J Med; 1977 Dec; 127(6):510-2. PubMed ID: 595589
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
    Huckell VF; Lyster DM; Morrison RT; Cooper JA
    Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of the technetium-99m stannous pyrophosphate myocardial scintigraphic "doughnut" pattern in patients with acute myocardial infarcts.
    Rude RE; Parkey RW; Bonte FJ; Lewis SE; Twieg D; Buja LM; Willerson JT
    Circulation; 1979 Apr; 59(4):721-30. PubMed ID: 421311
    [No Abstract]   [Full Text] [Related]  

  • 7. [Count density method for sizing myocardial infarction with Tc-99m-stannous pyrophosphate myocardial scintigraphy].
    Kiriyama T; Kondo T; Watanabe Y; Kaneko K; Kato Y; Sakurai M; Kurokawa H; Hishida H; Mizuno Y; Ejiri K
    Kaku Igaku; 1985 Jan; 22(1):75-9. PubMed ID: 3999458
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.
    Willerson JT; Parkey RW; Bonte FJ; Lewis SE; Corbett J; Buja LM
    Semin Nucl Med; 1980 Jan; 10(1):54-69. PubMed ID: 6246640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous display of gated technetium-99m stannous pyrophosphate and gated blood-pool scintigrams.
    Corbett JR; Lewis SE; Dehmer G; Bonte FJ; Parkey RW; Buja LM; Willerson JT
    J Nucl Med; 1981 Aug; 22(8):671-7. PubMed ID: 7264755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial 99mTc-pyrophosphate scintigraphy in acute heart infarct].
    Hole T; Rokkones T
    Tidsskr Nor Laegeforen; 1990 Feb; 110(5):596-7. PubMed ID: 2309208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The saga of scintigraphy in acute myocardial infarction.
    Bianco JA
    J Nucl Med; 1981 Aug; 22(8):739-42. PubMed ID: 7021773
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of nuclear imaging in patients with acute myocardial infarction.
    Williams BR
    Prim Care; 1981 Sep; 8(3):399-413. PubMed ID: 7031730
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathologic study of persistently positive technetium-99m stannous pyrophosphate myocardial scintigrams and myocytolytic degeneration after myocardial infarction.
    Buja LM; Poliner LR; Parkey RW; Pulido JI; Hutcheson D; Platt MR; Mills LJ; Bonte FJ; Willerson JT
    Circulation; 1977 Dec; 56(6):1016-23. PubMed ID: 923039
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium-99m stannous pyrophosphate myocardial scintiphotos in patients admitted to rule out acute myocardial infarction.
    Okada RD; Woolfenden JM; Raessler KL; Groves BM; Marcus RI
    Cardiology; 1977; 62(4-6):305-14. PubMed ID: 589613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear cardiology: an overview. Last of 3 parts.
    Slack JD; Smith ML; Nasser WK
    J Indiana State Med Assoc; 1983 Jan; 76(1):30-3. PubMed ID: 6827119
    [No Abstract]   [Full Text] [Related]  

  • 16. [Predictive value of myocardial scintigraphy using Tc Sn(II)-pyrophosphate in relation to the time of development of acute precordial pain].
    Cuarón A; Acero A; Cárdenas M
    Arch Inst Cardiol Mex; 1982; 52(4):283-93. PubMed ID: 7138132
    [No Abstract]   [Full Text] [Related]  

  • 17. Techniques for sizing myocardial infarction.
    Datz FL; Lewis SE; Stokely EM; Buja LM; Bonte FJ; Parkey RW; Willerson JT
    Crit Rev Diagn Imaging; 1981; 15(3):193-236. PubMed ID: 7016443
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential myocardial scintigraphy with technetium-99m stannous pyrophosphate following myocardial infarction.
    Malin FR; Rollo FD; Gertz EW
    J Nucl Med; 1978 Oct; 19(10):1111-5. PubMed ID: 722321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m(Sn2+)pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons.
    Bianco JA; Kemper AJ; Taylor A; Lazewatsky J; Tow DE; Khuri SF
    J Nucl Med; 1983 Jun; 24(6):485-91. PubMed ID: 6854398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial scintigraphy with technetium-99m stannous pyrophosphate: an insensitive test for nontransmural myocardial infarction.
    Massie BM; Botvinick EH; Werner JA; Chatterjee K; Parmley WW
    Am J Cardiol; 1979 Feb; 43(2):186-92. PubMed ID: 760473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.